Fang‐Ju Cheng

406 total citations
18 papers, 262 citations indexed

About

Fang‐Ju Cheng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fang‐Ju Cheng has authored 18 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Fang‐Ju Cheng's work include SARS-CoV-2 and COVID-19 Research (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Fang‐Ju Cheng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Fang‐Ju Cheng collaborates with scholars based in Taiwan, United States and South Korea. Fang‐Ju Cheng's co-authors include Wei‐Chien Huang, Chih‐Hsin Tang, Chih‐Yen Tu, Yeh Chen, Chia‐Shin Yang, Yang‐Chang Wu, Yi‐Cheng Shen, Ya-Ling Wei, Bowei Wang and Po‐Chun Chen and has published in prestigious journals such as Journal of Hazardous Materials, Oncogene and Nutrients.

In The Last Decade

Fang‐Ju Cheng

18 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fang‐Ju Cheng Taiwan	10	106	51	45	34	33	18	262
Jagadish Natesh India	13	188 1.8×	44 0.9×	77 1.7×	20 0.6×	21 0.6×	17	303
Shenghao Li China	12	166 1.6×	47 0.9×	42 0.9×	24 0.7×	33 1.0×	33	373
Aswathy R. Devan India	10	99 0.9×	83 1.6×	31 0.7×	28 0.8×	22 0.7×	18	303
Qingfeng Luo China	11	126 1.2×	30 0.6×	50 1.1×	48 1.4×	31 0.9×	39	323
Molly M. Hood United States	9	128 1.2×	78 1.5×	27 0.6×	46 1.4×	35 1.1×	19	421
Xinyu Huang China	12	143 1.3×	21 0.4×	57 1.3×	86 2.5×	28 0.8×	39	450
Federica Sarno Italy	14	277 2.6×	62 1.2×	35 0.8×	35 1.0×	20 0.6×	27	490
Dhanamjai Penta India	10	196 1.8×	40 0.8×	65 1.4×	19 0.6×	12 0.4×	13	302
Qin Sun China	10	152 1.4×	90 1.8×	17 0.4×	20 0.6×	37 1.1×	15	324
Guangpu Xue China	10	118 1.1×	33 0.6×	41 0.9×	31 0.9×	11 0.3×	17	303

Countries citing papers authored by Fang‐Ju Cheng

Since Specialization

Citations

This map shows the geographic impact of Fang‐Ju Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang‐Ju Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang‐Ju Cheng more than expected).

Fields of papers citing papers by Fang‐Ju Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang‐Ju Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang‐Ju Cheng. The network helps show where Fang‐Ju Cheng may publish in the future.

Co-authorship network of co-authors of Fang‐Ju Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Fang‐Ju Cheng. A scholar is included among the top collaborators of Fang‐Ju Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang‐Ju Cheng. Fang‐Ju Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Huang, Chih‐Hao, Fang‐Ju Cheng, Der‐Yen Lee, et al.. (2025). SLC6A14 Drives Mitochondrial Fusion and Oxidative Phosphorylation to Promote Cancer Stemness and Early‐Onset of Breast Cancer. Advanced Science. 12(45). e10811–e10811. 2 indexed citations

Chao, Chia‐Chia, et al.. (2024). Particulate matter facilitates amphiregulin-dependent lung cancer proliferation through glutamine metabolism. International Journal of Biological Sciences. 20(8). 3126–3139. 5 indexed citations

Chen, Chia‐Hung, Fang‐Ju Cheng, Bowei Wang, et al.. (2024). Incense-burning smoke ingredient Auramine enhances lincRNA-p21 expression for chemosensitization in p53-mutated non-small cell lung cancer. Journal of Hazardous Materials. 477. 135105–135105. 2 indexed citations

Huang, Yu-Wen, et al.. (2024). Cigarette smoke promotes IL-6-dependent lung cancer migration and osteolytic bone metastasis. International Journal of Biological Sciences. 20(9). 3257–3268. 8 indexed citations

Huang, Hui‐Chi, et al.. (2024). Artemisia argyi extracts overcome lapatinib resistance via enhancing TMPRSS2 activation in HER2‐positive breast cancer. Environmental Toxicology. 39(6). 3389–3399. 3 indexed citations

Wu, Yuying, Yu-Wen Huang, Nguyen Bao Tran, et al.. (2023). Glutamine metabolism controls amphiregulin-facilitated chemoresistance to cisplatin in human chondrosarcoma. International Journal of Biological Sciences. 19(16). 5174–5186. 7 indexed citations

Cheng, Fang‐Ju, Yeh Chen, Ya-Ling Wei, et al.. (2023). Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2. Cell & Bioscience. 13(1). 118–118. 10 indexed citations

Yeh, Ming-Hsin, Hsiao‐Fan Chen, Tsu‐Shing Wang, et al.. (2021). ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions. Molecular Therapy — Nucleic Acids. 25. 536–553. 17 indexed citations

Cheng, Fang‐Ju, Yi‐Cheng Shen, Chao‐Jung Chen, et al.. (2021). l‐lactic acidosis confers insensitivity to PKC inhibitors by competing for uptake via monocarboxylate transporters. Journal of Cellular Physiology. 237(1). 934–948. 1 indexed citations

10.

Chen, Chia‐Hung, Chun-Yi Wu, Fang‐Ju Cheng, et al.. (2021). PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs. Oncogene. 40(29). 4796–4808. 13 indexed citations

11.

Chao, Chia‐Chia, An‐Chen Chang, Po‐Chun Chen, et al.. (2021). Cigarette smoke-promoted increases in osteopontin expression attract mesenchymal stem cell recruitment and facilitate lung cancer metastasis. Journal of Advanced Research. 41. 77–87. 30 indexed citations

12.

Wang, Bowei, Chih‐Hao Huang, Liang‐Chih Liu, et al.. (2021). Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2. Frontiers in Pharmacology. 12. 614673–614673. 10 indexed citations

13.

Cheng, Fang‐Ju, Chia‐Shin Yang, Yi‐Cheng Shen, et al.. (2021). Hesperidin Is a Potential Inhibitor against SARS-CoV-2 Infection. Nutrients. 13(8). 2800–2800. 86 indexed citations

14.

Chen, Yeh, Wei‐Chien Huang, Chia‐Shin Yang, et al.. (2021). Screening strategy of TMPRSS2 inhibitors by FRET-based enzymatic activity for TMPRSS2-based cancer and COVID-19 treatment.. American Journal of Cancer Research. 11(3). 827–836. 10 indexed citations

15.

Sun, Xian Wen, Chia-Wei Li, Wei‐Jan Wang, et al.. (2020). Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinoma.. American Journal of Cancer Research. 10(2). 564–571. 21 indexed citations

16.

Tu, Chih‐Yen, Fang‐Ju Cheng, Chuan‐Mu Chen, et al.. (2018). Cigarette smoke enhances oncogene addiction to c‐MET and desensitizes EGFR‐expressing non‐small cell lung cancer to EGFR TKIs. Molecular Oncology. 12(5). 705–723. 21 indexed citations

17.

Tu, Chih‐Yen, Bowei Wang, Fang‐Ju Cheng, et al.. (2018). Incense burning smoke sensitizes lung cancer cells to EGFR TKI by inducing AREG expression.. PubMed. 8(12). 2575–2589. 6 indexed citations

18.

Li, Chien‐Chun, Hsien‐Tsung Yao, Fang‐Ju Cheng, et al.. (2015). Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells. Nutrition and Cancer. 67(5). 771–782. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact